Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02470585
Title Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Acronym VELIA
Recruitment Terminated
Gender female
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NZL | ISR | GBR | ESP | DNK | BRA | AUS


No variant requirements are available.